Pfizer’s 2025 lipid nanoparticle (LNP) production for mRNA therapies sources 80% of its lecithin from Cargill’s genetically optimized soy strains, which enhance drug encapsulation efficiency ...

global soy lecithin production increased by 12% in 2023, with a significant portion used in dairy alternatives, bakery products, and dietary supplements. Companies like ADM and Cargill are ...

Pfizer’s 2025 lipid nanoparticle (LNP) production for mRNA therapies sources 80% of its lecithin from Cargill’s genetically optimized soy strains, which enhance drug encapsulation efficiency by 30%.